Navigation Links
Walkaway automation for nucleic acid purification

GenoVision AS, an innovative biotechnology company offering complete walkaway automation for the isolation and purification of nucleic acids, is now part of the QIAGEN Group of Companies and is now known as QIAGEN AS. QIAGEN AS focuses on low- to medium-throughput purification of DNA and
RNA from a variety of blood and tissue samples using MagAttract magnetic-bead technology in combination with BioRobot M-Series workstations.

QIAGEN AS is a leader in the nucleic acid diagnostics and HLA-testing market, and has developed two BioRobot workstations for easy and reliable purification of nucleic acids. High-quality nucleic acids can be isolated from a variety of sample sources, including dried blood, leukocytes, serum, buccal cells, cultured cells, biopsies, paraffinembedded tissue sections, animal tissue, and yeast cells. The BioRobot M-Series workstations increase productivity by improving the reproducibility, speed, and quality of nucleic acid purification, providing a complete system with flexible sample throughput for walkaway automation.

QIAGEN AS offers two BioRobot M-Series workstations the BioRobot M48 and BioRobot M96. Each workstation has a secure closure for safe processing of samples, in order to shield the user and reduce noise. Internal modules and precision liquid handling ensure cross-contaminationfree purification of nucleic acids using proven MagAttract magnetic-bead technology. The BioRobot M48 provides flexible sample throughput with processing of up to 48 samples in increments of 6 samples per run. The BioRobot M96 allows processing of up to 96 samples in increments of 8 samples per run. Highly pure nucleic acid, suitable for sensitive downstream applications, c an be isolated from 6 or 8 samples in just 20 minutes. In addition, sample input volumes and elution volumes are variable, making your experiment more flexible and allowing you to isolate DNA at the optimal concentration for your downstream application. The BioRobot M96 can be used for specialized protocols such as isolation of DNA from dried blood spots, and it provides cost-effective isolation of nucleic acids from small sample volumes (i.e., 50 l). Easy-to-use QIAsoft M Operating System software is optimized for automated purification of nucleic acids, and eliminates the need to learn complex computer languages or command structures.

The BioRobot M-Series provides:
  • A complete solution for walkaway nucleic acid purification
  • Purification of high-quality DNA and RNA ready to use for sensitive downstream applications
  • Flexible sample throughput and a wide range of protocols
  • Cost-effective low- to medium-throughput nucleic acid purification



'"/>

Source:


Page: All 1 2

Related biology technology :

1. Laser microdissection and nucleic acid purification - a Leica - QIAGEN cooperation
2. Fully automated DNA purification and efficient multiplex PCR for analysis of microsatellite loci
3. DirectPrep 96 Miniprep System for cost-effective, high-throughput plasmid DNA purification
4. Ni-NTA Superflow Columns - automated large-scale purification of 6xHis-tagged proteins
5. New gravity-flow column gives faster and simpler purification of histidine-tagged proteins
6. DNA purification from pig ears to bird blood using proven DNeasy Technology
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... SAN DIEGO , March 29, 2017 /PRNewswire/ ... developing novel oncology and drug-delivery therapies, today announced ... U.S. Food and Drug Administration voted 11 to ... (under the skin) injection was favorable for patients ... large B-cell lymphoma and chronic lymphocytic leukemia. The ...
(Date:3/29/2017)... ... 2017 , ... Cancer diagnostics and pathology workflow solution provider ... Association of Community Cancer Centers (ACCC) 43rd Annual Meeting, CANCERSCAPE at ... stakeholders from leading national organizations to share insights on how value-based care, drug ...
(Date:3/29/2017)... NEWARK, Del. , March 29, 2017 ... medicine company, and W. L. Gore & ... announced a collaborative research agreement whereby the two companies ... delivery device technologies that provide protection from immune rejection. ... has been developing innovative stem cell-derived cell replacement therapies ...
(Date:3/29/2017)... Mar. 29, 2017 Research and Markets ... Technologies and Global Markets" report to their offering. ... The ... DNA sequencing, biochips, RNA interference, synthetic biology tools and genome ... biologicals. These technologies and products are analyzed to ...
Breaking Biology Technology:
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/7/2017)... March 7, 2017   HireVue , the leading ... companies identify the best talent, faster, today announced the ... Officer (CSO) and Diana Kucer as Chief ... seasoned executive team poised to drive continued growth in ... a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Summary This report ... Merck KGaA and its partnering interests and activities since ... Description The Partnering Deals and Alliance since 2010 ... of one of the world,s leading life sciences companies. ... purchase to ensure inclusion of the most up to ...
Breaking Biology News(10 mins):